Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127619731 | 12761973 | 1 | I | 20160830 | 20160920 | 20160920 | EXP | PHHY2016BR122375 | SANDOZ | 0.00 | F | Y | 0.00000 | 20160920 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127619731 | 12761973 | 1 | PS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 240 MG, QD | Y | FU1535 | 0 | 240 | MG | MODIFIED RELEASE TABLET | QD | ||||
| 127619731 | 12761973 | 2 | SS | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 120 MG, BID | Y | FU1535 | 0 | 120 | MG | MODIFIED RELEASE TABLET | BID | ||||
| 127619731 | 12761973 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 2 DF, QD, 4 OR 5 YEARS AGO | U | 0 | 2 | DF | QD | ||||||
| 127619731 | 12761973 | 4 | C | ARADOIS H | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 2 DF, QD, 1 MONTH AGO | U | 0 | 2 | DF | QD | ||||||
| 127619731 | 12761973 | 5 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 127619731 | 12761973 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 0.5 DF, UNK, 1 WEEK AGO | U | 0 | .5 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127619731 | 12761973 | 1 | Hypertension |
| 127619731 | 12761973 | 3 | Hypertension |
| 127619731 | 12761973 | 4 | Hypertension |
| 127619731 | 12761973 | 5 | Depression |
| 127619731 | 12761973 | 6 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127619731 | 12761973 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127619731 | 12761973 | Blood cholesterol increased | |
| 127619731 | 12761973 | Blood pressure fluctuation | |
| 127619731 | 12761973 | Blood pressure increased | |
| 127619731 | 12761973 | Drug administration error | |
| 127619731 | 12761973 | Glucose tolerance impaired | |
| 127619731 | 12761973 | Kidney angiomyolipoma | |
| 127619731 | 12761973 | Rheumatoid arthritis | |
| 127619731 | 12761973 | Vitamin D deficiency | |
| 127619731 | 12761973 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127619731 | 12761973 | 5 | 2016 | 0 |